A citation-based method for searching scientific literature

Y Wahedna, A J Evans, S E Pinder, I O Ellis, R W Blamey, J G Geraghty. Eur J Cancer 2001
Times Cited: 27







List of co-cited articles
135 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
251
66

The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy.
Lidewij E Hoorntje, Marguerite E I Schipper, Petra H M Peeters, Frank Bellot, Remmert K Storm, Inne H M Borel Rinkes. Ann Surg Oncol 2003
66
66

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
204
59

A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
T A King, G H Farr, G J Cederbom, D H Smetherman, J S Bolton, A J Stolier, G M Fuhrman. Am Surg 2001
44
55

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
97
55

Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?
C H Lee, D Carter, L E Philpotts, M E Couce, L J Horvath, R C Lange, I Tocino. Radiology 2000
110
51


Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Lisa A Rutstein, Ronald R Johnson, William R Poller, David Dabbs, Jan Groblewski, Tina Rakitt, Allan Tsung, Thomas Kirchner, Jules Sumkin, Donald Keenan,[...]. Breast J 2007
45
40


Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
P Meijnen, H S A Oldenburg, C E Loo, O E Nieweg, J L Peterse, E J T Rutgers. Br J Surg 2007
64
40

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
73
40

Predicting invasion in mammographically detected microcalcification.
M J Bagnall, A J Evans, A R Wilson, S E Pinder, H Denley, J G Geraghty, I O Ellis. Clin Radiol 2001
51
33

Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.
M L Darling, D N Smith, S C Lester, C Kaelin, D L Selland, C M Denison, P J DiPiro, D I Rose, E Rhei, J E Meyer. AJR Am J Roentgenol 2000
207
33

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Caren Wilkie, Laura White, Elisabeth Dupont, Alan Cantor, Charles E Cox. Am J Surg 2005
93
33

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
N Klauber-DeMore, L K Tan, L Liberman, S Kaptain, J Fey, P Borgen, A Heerdt, L Montgomery, M Paglia, J A Petrek,[...]. Ann Surg Oncol 2000
228
29

Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy.
Michelle Bonnett, Tracy Wallis, Michelle Rossmann, Nat L Pernick, Kathryn A Carolin, Mark Segel, David Bouwman, Daniel Visscher. Mod Pathol 2002
26
30

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Elizabeth A Mittendorf, Cletus A Arciero, Veronica Gutchell, Jeff Hooke, Craig D Shriver. Curr Surg 2005
67
29

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
54
29

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
224
29


Percutaneous large-core breast biopsy: a multi-institutional study.
S H Parker, F Burbank, R J Jackman, C J Aucreman, G Cardenosa, T M Cink, J L Coscia, G W Eklund, W P Evans, P R Garver. Radiology 1994
548
25


Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.
R F Brem, J M Schoonjans, S N Goodman, A Nolten, F B Askin, O M Gatewood. Radiology 2001
55
22

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
30
22

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
38
22


Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.
Mattia Intra, Paolo Veronesi, Giovanni Mazzarol, Viviana Galimberti, Alberto Luini, Virgilio Sacchini, Giuseppe Trifirò, Oreste Gentilini, Giancarlo Pruneri, Paola Naninato,[...]. Arch Surg 2003
120
18

Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsy.
I Méndez, F J Andreu, E Sáez, M Sentís, I Jurado, M A Cabezuelo, E Castañer, X Gallardo, M J Díaz-Ruiz, E López,[...]. Breast J 2001
17
29

Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions.
Steven Pandelidis, David Heiland, David Jones, Kelly Stough, Joanne Trapeni, Yasir Suliman. Ann Surg Oncol 2003
66
18

Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ.
Edna May L Go, Siu-Ki Chan, Joaquim S L Vong, Philip C W Lui, Anthony W H Chan, Tony K F Ma, Mark A Ang, Bonita K B Law, Puay-Hoon Tan, Gary M Tse. Mod Pathol 2010
19
26

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Jensen C C Tan, David R McCready, Alexandra M Easson, Wey L Leong. Ann Surg Oncol 2007
45
18

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
34
18

Sentinel node biopsy in ductal carcinoma in situ patients.
S Pendas, E Dauway, R Giuliano, N Ku, C E Cox, D S Reintgen. Ann Surg Oncol 2000
139
14

Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions.
W E Burak, K E Owens, M B Tighe, L Kemp, S A Dinges, C L Hitchcock, J Olsen. Arch Surg 2000
126
14

Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ.
R Holland, J H Hendriks, A L Vebeek, M Mravunac, J H Schuurmans Stekhoven. Lancet 1990
426
14


Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.
Giorgio Zavagno, Paolo Carcoforo, Renato Marconato, Zeno Franchini, Giuliano Scalco, Paolo Burelli, Paolo Pietrarota, Mario Lise, Roberto Mencarelli, Giovanni Capitanio,[...]. BMC Cancer 2005
41
14

Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
M F Dillon, C M Quinn, E W McDermott, A O'Doherty, N O'Higgins, A D K Hill. J Clin Pathol 2006
18
22

Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Cathal J Moran, Malcolm R Kell, Fidelma L Flanagan, Maria Kennedy, Thomas F Gorey, Michael J Kerin. Am J Surg 2007
35
14

Sentinel lymph node biopsy for localised ductal carcinoma in situ?
P Veronesi, M Intra, A R Vento, P Naninato, P Caldarella, G Paganelli, G Viale. Breast 2005
60
14

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
14

Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies.
Stefano Ciatto, Nehmat Houssami, Daniela Ambrogetti, Simonetta Bianchi, Rita Bonardi, Beniamino Brancato, Sandra Catarzi, Gabriella G Risso. Breast Cancer Res Treat 2007
89
14

Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy.
Junnu Leikola, Päivi Heikkilä, Martti Pamilo, Kaisa Salmenkivi, Karl Von Smitten, Marjut Leidenius. Acta Oncol 2007
10
40

Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
32
14

Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus.
Jong Won Lee, Wonshik Han, Eunyoung Ko, Jihyoung Cho, Eun-Kyu Kim, So-Youn Jung, Nariya Cho, Woo Kyung Moon, In-Ae Park, Dong-Young Noh. J Surg Oncol 2008
38
14

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
43
14

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
51
14

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
184
14

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
194
14

The sentinel node in breast cancer--a multicenter validation study.
D Krag, D Weaver, T Ashikaga, F Moffat, V S Klimberg, C Shriver, S Feldman, R Kusminsky, M Gadd, J Kuhn,[...]. N Engl J Med 1998
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.